Cases & Deals

IntegraGen closes €6.72 million private placement and subsequent IPO

Clients IntegraGen

Jones Day advised IntegraGen, a pioneer in the development of molecular diagnostic products and services, in connection with its €6.72 million (US$8.3 million) private placement to qualified investors, including BIOAM Gestion, CDC Enterprises, CDC Innovation, and IDInvest Partners, and subsequent initial public offering on the Alternext Market of NYSE Euronext Paris.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.